Dr Pascale Mardikian LLC is categorized under Family Practice Doctors in Charleston, SC and active since 2012.
Dr Pascale Mardikian LLC was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Pascale N Mardikian at the company’s single location by writing to 9263 Medical Plaza Drive A, Charleston, South Carolina SC 29406 or by phoning (843) 377-1600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Dr Pascale Mardikian LLC |
Contact Person: | Pascale N Mardikian |
Address: | 9263 Medical Plaza Drive A, Charleston, South Carolina 29406 |
Phone Number: | (843) 377-1600 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2012 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Family Practice Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Dr Pascale Mardikian LLC was started in 2012 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Pascale N Mardikian for inquiries that concern Dr Pascale Mardikian LLC by calling the company number (843) 377-1600, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr Pascale Mardikian LLC can be found at the coordinates 32.975011,-80.072175 as well as the street address 9263 Medical Plaza Drive A in Charleston, South Carolina 29406.
For its online presence, you may visit Dr Pascale Mardikian LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.